bosentan anhydrous has been researched along with Fever in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Figueiredo, MJ; Kanashiro, A; Machado, RR; Malvar, Ddo C; Martins, JM; Pessini, AC; Roth, J; Soares, DM; Souza, GE | 1 |
| Allanore, Y; Isvy, A; Kahan, A; Maury, E; Moachon, L | 1 |
| García-Consuegra, J; González-Fernández, MA | 1 |
3 other study(ies) available for bosentan anhydrous and Fever
| Article | Year |
|---|---|
CCL3/MIP-1 alpha is not involved in the LPS-induced fever and its pyrogenic activity depends on CRF.
Topics: Animals; Antibodies, Monoclonal; Antihypertensive Agents; Bosentan; Chemokine CCL3; Corticotropin-Releasing Hormone; Drug Interactions; Endothelin-1; Fever; Injections, Intraventricular; Lipopolysaccharides; Macrophages; Male; Mice; Peptide Fragments; Rats; Rats, Wistar; Recombinant Proteins; Sulfonamides | 2009 |
Bosentan-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome.
Topics: Aged; Anti-Ulcer Agents; Bosentan; Drug Hypersensitivity; Eosinophilia; Exanthema; Female; Fever; Humans; Scleroderma, Systemic; Sulfonamides; Syndrome | 2010 |
Polyarteritis nodosa resistant to conventional treatment in a pediatric patient.
Topics: Anti-Inflammatory Agents; Antihypertensive Agents; Arthralgia; Azathioprine; Bosentan; Child, Preschool; Cyclophosphamide; Female; Fever; Humans; Iloprost; Immunoglobulins, Intravenous; Immunosuppressive Agents; Methylprednisolone; Polyarteritis Nodosa; Sulfonamides; Vasodilator Agents | 2007 |